Literature DB >> 12222709

Decline of maternal hepatitis A virus antibody levels in infants.

A De Silvestri1, M A Avanzini, V Terulla, S Zucca, F Polatti, C Belloni.   

Abstract

UNLABELLED: Hepatitis A is a common viral infection causing substantial morbidity and mortality. The anti-hepatitis A virus (HAV) vaccination in infants would guarantee control of the infection. However, the immunogenicity of the HAV vaccine in infants could be impaired by the presence of passively acquired maternal HAV antibodies. This study evaluated the prevalence of HAV antibodies in 103 women at delivery and in their babies in the first year of life. Eighteen mothers (17.5%) had anti-HAV serum level >10 mIU ml(-1). In their infants the anti-HAV level was still positive in 11 out of 18 (61.1%) at 12 mo. Two out of 85 infants born to anti-HAV-negative mothers and anti-HAV negative at birth were found to be positive at 5 mo of age.
CONCLUSION: It is proposed that all women be screened at delivery for anti-HAV antibodies. Children born to anti-HAV-negative mothers could be vaccinated early during the first year of life, whereas vaccination could be postponed in children born to anti-HAV-positive mothers, if necessary.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12222709     DOI: 10.1080/080352502760148577

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  1 in total

1.  Determining the persistence of maternally acquired antibodies to hepatitis A and varicella zoster during the first 2 years of life in Turkey.

Authors:  Fırat Begde; Filiz Simsek Orhon; Devran Gerceker; Betul Ulukol; Seda Topcu; Sevgi Baskan
Journal:  Eur J Pediatr       Date:  2015-01-07       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.